MENU
+Compare
BDX
Stock ticker: NYSE
AS OF
Feb 3, 04:59 PM (EDT)
Price
$206.45
Change
+$17.37 (+9.19%)
Capitalization
57.53B

BDX Becton Dickinson and Co Forecast, Technical & Fundamental Analysis

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units... Show more

BDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BDX with price predictions
Feb 02, 2026

BDX's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for BDX moved out of overbought territory on January 07, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where BDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BDX as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BDX turned negative on January 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BDX broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BDX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 203 cases where BDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.266) is normal, around the industry mean (11.444). P/E Ratio (34.692) is within average values for comparable stocks, (149.532). Projected Growth (PEG Ratio) (1.038) is also within normal values, averaging (2.462). Dividend Yield (0.021) settles around the average of (0.017) among similar stocks. P/S Ratio (2.667) is also within normal values, averaging (110.694).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDX is expected to report earnings to fall 29.04% to $2.81 per share on February 09

Becton Dickinson and Co BDX Stock Earnings Reports
Q4'25
Est.
$2.81
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.28
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.44
The last earnings report on November 06 showed earnings per share of $3.96, beating the estimate of $3.92. With 895.52K shares outstanding, the current market capitalization sits at 57.53B.
A.I.Advisor
published Dividends

BDX paid dividends on December 31, 2025

Becton Dickinson and Co BDX Stock Dividends
А dividend of $1.05 per share was paid with a record date of December 31, 2025, and an ex-dividend date of December 08, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of medical supplies, devices, laboratory equipment and diagnostic products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1 Becton Drive
Phone
+1 201 847-6800
Employees
72000
Web
https://www.bd.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DGIN39.731.41
+3.68%
VanEck Digital India ETF
QQQI54.200.37
+0.69%
NEOS Nasdaq-100(R) High Income ETF
YDEC26.860.08
+0.30%
FT Vest Intl Eq Mod Bffr ETF Dec
IIM12.40-0.01
-0.08%
INVESCO VALUE Municipal Income TRUST
SHEH54.44-0.76
-1.38%
SHELL PLC ADRHEDGED SHEH

BDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TMO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
-0.77%
TMO - BDX
50%
Loosely correlated
+0.55%
CNMD - BDX
48%
Loosely correlated
+2.14%
RVTY - BDX
45%
Loosely correlated
-1.57%
STE - BDX
44%
Loosely correlated
+0.62%
ALC - BDX
44%
Loosely correlated
-1.98%
More

Groups containing BDX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
-0.77%
Pharmaceuticals
category (380 stocks)
52%
Loosely correlated
+27.23%
Pharmaceuticals: Other
category (107 stocks)
51%
Loosely correlated
-0.39%